4.7 Article

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

Lei Shi et al.

Summary: The study found that UC-MSC treatment has a positive effect on the long-term recovery of COVID-19 patients, improving lung lesions and reducing symptoms. Compared to the placebo group, more patients in the MSC group had normal CT images at 12 months.

EBIOMEDICINE (2022)

Article Urology & Nephrology

AKI in Hospitalized Patients with COVID-19

Lili Chan et al.

Summary: The study found that AKI is common among hospitalized COVID-19 patients in the United States, with a 46% occurrence rate and 19% of patients requiring dialysis. Independently predicting severe AKI were chronic kidney disease, male gender, and higher serum potassium levels at admission. In-hospital mortality was significantly higher in patients with AKI compared to those without AKI, with only 30% of AKI patients recovering kidney function by the time of discharge.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Acute kidney injury in patients with Covid-19 in a Brazilian ICU: incidence, predictors and in-hospital mortality

Rafael Lessa da Costa et al.

Summary: The study found a high incidence of AKI in COVID-19 patients in the ICU, with age, eGFR, and hypertension as predictive factors for AKI. AKI was associated with higher hospital mortality.

JORNAL BRASILEIRO DE NEFROLOGIA (2021)

Article Cell Biology

Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

Rongjia Zhu et al.

Summary: Treatment of COVID-19 patients with mesenchymal stem cells (MSCs) showed positive outcomes in terms of shorter hospital stays, faster symptom remission, and improved chest images, with reduced adverse events. MSC infusion modulated the immune system by decreasing inflammatory markers, promoting SARS-CoV-2-specific antibodies, and activating specific immune cell populations. Furthermore, MSCs suppressed NET release and reduced venous thrombosis, highlighting their role in improving patient outcomes via immune homeostasis.

CELL RESEARCH (2021)

Article Respiratory System

Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19

Tori Vigeland Lerum et al.

Summary: The long-term pulmonary outcomes of COVID-19 after 3 months of hospital admission include chest CT opacities and reduced diffusing capacity in one-fourth of the participants. ICU patients did not show significant differences in dyspnoea scores and lung function, but had a higher prevalence of abnormal chest CT findings.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Medical Laboratory Technology

Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19

Salvador Payan-Pernia et al.

Summary: The study found that ferritin, LDH, ALC, and CRP can predict the probability of early MIV with 88% accuracy. Among these parameters, LDH showed the highest AUC value of 89.1%. The study established cutoff values and developed a classification tree based on LDH for clinical use.

LABORATORY MEDICINE (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Review Biochemistry & Molecular Biology

COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far

Mujeeb Khan et al.

Summary: The article summarizes the three deadly pandemics associated with novel coronaviruses that humans have witnessed in the twenty-first century: SARS, MERS, and COVID-19. Specifically, it describes the epidemiological characteristics of COVID-19, such as transmission, death rate, and discusses various treatment strategies and different approaches to vaccine development.

MOLECULES (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Giacomo Lanzoni et al.

Summary: The study confirmed safety of UC-MSC infusions in patients with COVID-19 ARDS. By reducing inflammatory cytokines, significant improvement was observed in UC-MSC-treated patients on day 6. The treatment markedly increased patient survival rate, SAE-free survival, and time to recovery.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Critical Care Medicine

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

Otavio T. Ranzani et al.

Summary: A total of 254,288 patients with RT-qPCR-confirmed COVID-19 were admitted to hospitals in Brazil, with an overall in-hospital mortality rate of 38%, rising to 59% in ICU patients and 80% in those on ventilators. The burden of ICU admissions and mortality rates varied across different regions of the country, emphasizing the need for improved healthcare access for critically ill COVID-19 patients, especially in low- and middle-income countries.

LANCET RESPIRATORY MEDICINE (2021)

Article Immunology

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients

Lili Li et al.

Summary: The study identified IL-8 as a biomarker to predict disease severity and prognosis of COVID-19 patients, showing that IL-8 is more distinct for mild cases compared to IL-6.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell & Tissue Engineering

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

Seyed-Mohammad Reza Hashemian et al.

Summary: This study investigated the safety and effectiveness of multiple high-dose infusions of MSCs derived from placenta and umbilical cord in critically ill COVID-19-induced ARDS patients. Some patients showed significant improvement in respiratory distress and reduction in inflammatory markers after cell infusions.

STEM CELL RESEARCH & THERAPY (2021)

Review Physiology

Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies

Miqueias Lopes-Pacheco et al.

Summary: SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, with the ability to infect human cells through binding to ACE2. This can lead to multi-organ dysfunction syndrome, highlighting the importance of understanding the virus's biology and pathogenesis for identifying effective therapies.

FRONTIERS IN PHYSIOLOGY (2021)

Article Immunology

High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19

Aiping Ma et al.

Summary: The study found a positive association between the duration of illness in patients with severe COVID-19 and serum levels of IL-8 and soluble IL-2R alpha, indicating the involvement of neutrophils and T cells in the evolution of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Letter Medicine, General & Internal

Sequelae in Adults at 6 Months After COVID-19 Infection

Jennifer K. Logue et al.

JAMA NETWORK OPEN (2021)

Article Infectious Diseases

Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality

Katia Lino et al.

Summary: This study found a significant association between ferritin levels at admission and in-hospital mortality in COVID-19 patients, with high ferritin levels independently predicting mortality.

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2021)

Review Pharmacology & Pharmacy

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases

Sara Rolandsson Enes et al.

Summary: Advancements in cell-based therapies for lung diseases and critical illnesses show promise, but translating efficacy from preclinical to clinical settings has been challenging due to limited understanding of MSCs' interaction with the host environment. Challenges for MSC cell therapies include cell sources, dosing, disease targets, donor variability, and cell product manufacturing.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Patients with COVID-19: in the dark-NETs of neutrophils

Maximilian Ackermann et al.

Summary: SARS-CoV-2 infection poses a major threat to multiple organs, with severe cases showing dysregulated immune responses. The imbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of severe COVID-19 cases. Therapeutic strategies targeting dysregulated NET formation or degradation may benefit severe COVID-19 patients.

CELL DEATH AND DIFFERENTIATION (2021)

Article Multidisciplinary Sciences

Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study

Tarek Abdel Latif Ghonimi et al.

Summary: This study investigated the mortality and risk factors of COVID-19 infection in maintenance dialysis patients in Qatar, finding a higher incidence and mortality rate compared to the general population. A strong association was observed between death related to COVID-19 infection in dialysis patients and admission to ICU.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology

Hakki Arikan et al.

Summary: Advanced-stage AKI is associated with extremely high mortality among hospitalized COVID-19 patients. Age, male gender, comorbidities, which are risk factors for mortality in patients with COVID-19 in the general population, are also related to in-hospital mortality in patients with AKI. Preexisting non-dialysis CKD did not increase in-hospital mortality rate among AKI patients.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT

Melanie L. Bell et al.

Summary: Clinical presentation, outcomes, and duration of COVID-19 vary greatly among individuals. Most PASC research has focused on hospitalized patients. A population-based study in Arizona found that 68.7% of non-hospitalized individuals experienced PASC symptoms 30 days post-infection, with fatigue, shortness-of-breath, brain fog, and stress/anxiety being the most common symptoms.

PLOS ONE (2021)

Article Cell & Tissue Engineering

Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial

Mahshid Saleh et al.

Summary: The study evaluated the safety and efficacy of intravenous Wharton's jelly-derived MSCs in treating COVID-19 patients. Results showed improvement in inflammation responses and no serious complications, indicating that severe COVID-19 patients in the inflammatory phase may respond well to cell therapy. More extensive clinical trials are needed in this area.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial

Ismail Hadisoebroto Dilogo et al.

Summary: The use of umbilical cord mesenchymal stromal cells (UC-MSCs) as adjuvant treatment for critically ill patients with COVID-19 significantly increases the survival rate by modulating the immune system towards an anti-inflammatory state.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Microbiology

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Amy D. Proal et al.

Summary: The novel coronavirus SARS-CoV-2 has led to a pandemic of COVID-19, with some patients developing persistent symptoms known as Long COVID or PASC. These patients may have different underlying biological factors driving their symptoms, such as organ damage, persistent viral reservoirs, re-activation of pathogens, and immune dysregulation. Therapeutic approaches may need to be individualized to effectively manage care for specific patients with PASC.

FRONTIERS IN MICROBIOLOGY (2021)

Article Critical Care Medicine

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Davies Adeloye et al.

Summary: An international consensus exercise was conducted to identify research priorities for understanding the long-term effects of acute COVID-19, focusing on individuals with pre-existing airways disease. High priority was given to investigations on prognostic scores at hospital admission and morbidity at 3 months and 12 months after hospital discharge, as well as comparisons of prevalence and severity of post-COVID-19 symptoms between patients with and without pre-existing airways disease.

LANCET RESPIRATORY MEDICINE (2021)

Review Cell & Tissue Engineering

Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19

Dhavan Sharma et al.

Summary: Allogenic MSC infusion is safe and effective in COVID-19 patients with ARDS, reducing inflammatory cytokines and improving patient survival and recovery time, supporting further investigation into larger clinical trials for this group of patients.

NPJ REGENERATIVE MEDICINE (2021)

Article Respiratory System

Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients

Stine Johnsen et al.

Summary: The study found that three months after COVID-19 infection, patients still exhibited persistent symptoms and various abnormalities in respiratory, pulmonary, cardiac, physical, and cognitive aspects, which were more pronounced in hospitalized patients. The findings emphasize the importance of multidimensional management strategies in these patients.

ERJ OPEN RESEARCH (2021)

Article Cell & Tissue Engineering

The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial

G. Adas et al.

Summary: The aim of the clinical trial was to control cytokine storm by administering MSCs to critically ill COVID-19 patients, evaluating healing effects, and systematically investigating treatment mechanisms. The results showed positive systematic and cellular effects of MSCs application in critically ill patients, playing an important role in curing and reducing mortality.

CELL TRANSPLANTATION (2021)

Article Biochemistry & Molecular Biology

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Lei Shi et al.

Summary: This study demonstrates that treatment with human umbilical cord-mesenchymal stem cells (UC-MSCs) can significantly improve lung lesions in COVID-19 patients and potentially have therapeutic effects in the 6-minute walk test. The incidence of adverse events was similar in both groups, indicating the good safety profile of UC-MSCs treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Cell & Tissue Engineering

Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19

Pinky et al.

Summary: The global pandemic caused by the novel coronavirus strain is a major concern, with efforts being made to find effective treatments. Mesenchymal Stem Cells-derived exosomes are considered a promising therapeutic agent with potential applications in combating the current pandemic.

STEM CELL REVIEWS AND REPORTS (2021)

Article Medicine, General & Internal

Mean serum D-dimer level to predict in-hospital mortality in COVID-19

Mertilker Hayiroglu et al.

Summary: This study aimed to evaluate the effect of mean D-dimer level on in-hospital mortality in patients hospitalized due to COVID-19 infection. The results showed that patients with a higher mean D-dimer level had a significantly higher risk of in-hospital mortality.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2021)

Article Biochemistry & Molecular Biology

Heparin improves alveolarization and vascular development in hyperoxia-induced bronchopulmonary dysplasia by inhibiting neutrophil extracellular traps

Yuanyuan Sun et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia

Kunhua Li et al.

INVESTIGATIVE RADIOLOGY (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Immunology

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Meijuan Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Immunology

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Fan Wang et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Review Biotechnology & Applied Microbiology

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

Dae-Gyun Ahn et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Review Virology

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Yuefei Jin et al.

VIRUSES-BASEL (2020)

Editorial Material Respiratory System

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Alice Huertas et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Medicine, General & Internal

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Giacomo Grasselli et al.

JAMA INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Vascular occlusion by neutrophil extracellular traps in COVID-19

Moritz Leppkes et al.

EBIOMEDICINE (2020)

Article Urology & Nephrology

Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis

Shelief Y. Robbins-Juarez et al.

Kidney International Reports (2020)

Article Immunology

Single-cell landscape of immunological responses in patients with COVID-19

Ji-Yuan Zhang et al.

NATURE IMMUNOLOGY (2020)

Editorial Material Medicine, General & Internal

Long-term Health Consequences of COVID-19

Carlos del Rio et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Transplantation

Targeting acute kidney injury in COVID-19

John A. Kellum et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Review Cell Biology

The COVID-19 pandemic: a global health crisis

Casey A. Pollard et al.

PHYSIOLOGICAL GENOMICS (2020)

Article Chemistry, Medicinal

Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19

Chenghai Li et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Article Cell & Tissue Engineering

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

COVID-19 hospitalizations in Brazil's Unified Health System (SUS)

Carla Lourenco Tavares de Andrade et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19

Milad Sharifpour et al.

PLOS ONE (2020)

Article Critical Care Medicine

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Jesus F. Bermejo-Martin et al.

CRITICAL CARE (2020)

Article Endocrinology & Metabolism

D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases

Mamta Soni et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Biochemistry & Molecular Biology

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

Yu Chen et al.

MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial

Fanping Meng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Medicine, General & Internal

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

Abdurrahman Tufan et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2020)

Article Public, Environmental & Occupational Health

Mortality and survival of COVID-19

G. J. B. Sousa et al.

EPIDEMIOLOGY AND INFECTION (2020)

Article Biochemical Research Methods

EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets

Juan Flores-Montero et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2019)

Review Immunology

The Immunology of Macrophage Activation Syndrome

Courtney B. Crayne et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Cell & Tissue Engineering

Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats

Xiaoli Li et al.

STEM CELL RESEARCH & THERAPY (2018)

Article Computer Science, Interdisciplinary Applications

Gaussian Copula Regression in R

Guido Masarotto et al.

JOURNAL OF STATISTICAL SOFTWARE (2017)

Review Cell & Tissue Engineering

The exciting prospects of new therapies with mesenchymal stromal cells

Darwin J. Prockop

CYTOTHERAPY (2017)

Review Medicine, Research & Experimental

Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies

Grant S. Schulert et al.

ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)

Review Pharmacology & Pharmacy

Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?

Sheila K. Patel et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)

Review Biotechnology & Applied Microbiology

Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation

Darwin J. Prockop et al.

MOLECULAR THERAPY (2012)

Article Statistics & Probability

Gaussian copula marginal regression

Guido Masarotto et al.

ELECTRONIC JOURNAL OF STATISTICS (2012)

Article Multidisciplinary Sciences

Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells

Wolfgang Wagner et al.

PLOS ONE (2009)

Article Cell & Tissue Engineering

Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

Uwe M. Fischer et al.

STEM CELLS AND DEVELOPMENT (2009)

Article Medicine, Research & Experimental

Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue

C. K. Rebelatto et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2008)

Article Cell Biology

Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies

A. Stolzing et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2008)

Article Biochemistry & Molecular Biology

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

K Kuba et al.

NATURE MEDICINE (2005)